Cargando…
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
AIMS/INTRODUCTION: The cardiovascular (CV) outcomes of vildagliptin – a dipeptidyl peptidase‐4 inhibitor – in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke are unclear. MATERIALS AND METHODS: We analyzed data from the Taiwan National Health Insurance R...
Autores principales: | Chen, Dong‐Yi, Li, Yan‐Rong, Mao, Chun‐Tai, Tseng, Chi‐Nan, Hsieh, I‐Chang, Hung, Ming‐Jui, Chu, Pao‐Hsien, Wang, Chao‐Hung, Wen, Ming‐Shien, Cherng, Wen‐Jin, Chen, Tien‐Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944835/ https://www.ncbi.nlm.nih.gov/pubmed/31115964 http://dx.doi.org/10.1111/jdi.13078 |
Ejemplares similares
-
Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
por: Mao, Chun-Tai, et al.
Publicado: (2019) -
Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study
por: Liang, Chung-Yu, et al.
Publicado: (2018) -
Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee, Chen-Hung, et al.
Publicado: (2019) -
Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization
por: Mao, Chun-Tai, et al.
Publicado: (2016) -
Outcomes and Characteristics of Patients Undergoing Percutaneous Angioplasty Followed by Below-Knee or Above-Knee Amputation for Peripheral Artery Disease
por: Mao, Chun-Tai, et al.
Publicado: (2014)